CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- 4 Grant or award President & CEO acquired 60,200 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 10,095 shares (grant or award)
- 4 Grant or award Director acquired 6,175 shares (grant or award)
- 4 Grant or award Director acquired 3,355 shares (grant or award)
- 4 Open-market buy 10% owner bought 1,061,277 shares at an average $7.19 ($7,631,469)
- 4 Option exercise Director acquired 12,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 1,000,000 shares at an average $5.96 ($5,958,107)
- 4 Open-market buy 10% owner bought 1,542,857 shares at $3.50 ($5,400,000)
- 4 Open-market buy 10% owner bought 2,857,142 shares at $3.50 ($9,999,997)
Page 1 of 9 · 176 filings